Practice English Speaking&Listening with: Remdesivir showing promise in COVID-19 fight

Normal
(0)
Difficulty: 0

PART IN ONE OF THE STUDIES MAKING BIG HEADLINES TONIGHT.

MAKING BIG HEADLINES TONIGHT. >> GOOD EVENING I A KRIS DUE

>> GOOD EVENING I A KRIS DUE FARES AND I AM IN FOR DOMINICK

FARES AND I AM IN FOR DOMINICK TEEN.

TEEN. ITS CALLED REMEDIES VEER AND

ITS CALLED REMEDIES VEER AND PATIENTS SHOWED IMPROVEMENT

PATIENTS SHOWED IMPROVEMENT QUICKLY WHEN TREATED WITH IT.

QUICKLY WHEN TREATED WITH IT. >> ONE STUDY IS PANEL HAPPENING

>> ONE STUDY IS PANEL HAPPENING HERE NO HOUSTON THE DOCTORS AT

HERE NO HOUSTON THE DOCTORS AT METH HOSPITAL ARE ON THE

METH HOSPITAL ARE ON THE FRONTLINE OF THE NEW RESEARCH,

FRONTLINE OF THE NEW RESEARCH, RIGHT, BILL?

RIGHT, BILL? >> Reporter: THATS RIGHT, AND

>> Reporter: THATS RIGHT, AND IN REGARDS TO THAT STUDY, THERE

IN REGARDS TO THAT STUDY, THERE ARE SEVERAL STUDIES REGARDING

ARE SEVERAL STUDIES REGARDING THAT DRUG SOME OF WHICH DOCTORS

THAT DRUG SOME OF WHICH DOCTORS ARE HELPING WITH.

ARE HELPING WITH. HER TELLING US THEY ARE

HER TELLING US THEY ARE CAUTIOUSLY OPTIMISTIC THAT THE

CAUTIOUSLY OPTIMISTIC THAT THE DRUG COULD HELP SPAY SHE WANTS

DRUG COULD HELP SPAY SHE WANTS SUFFERING FROM SEVERE SYMPTOMS

SUFFERING FROM SEVERE SYMPTOMS OF CORONAVIRUS IT, COULD HELP

OF CORONAVIRUS IT, COULD HELP THEM RECOVER.

THEM RECOVER. DOCTORS RESEARCHERS AND

DOCTORS RESEARCHERS AND SCIENTISTS HAVE BEEN WORKING

SCIENTISTS HAVE BEEN WORKING UNDER THE LOCK AT THE HE WANT OF

UNDER THE LOCK AT THE HE WANT OF THEIR STUDS AND TRIES AN

THEIR STUDS AND TRIES AN EXPERIMENTAL DRUG KNOWN AS

EXPERIMENTAL DRUG KNOWN AS REMEDIES VEER.

REMEDIES VEER. >> EVERYBODY, RESEARCH RERS,

>> EVERYBODY, RESEARCH RERS, WHAT I THINKS IT,SCLINICIANS, HO

WHAT I THINKS IT,SCLINICIANS, HO INSTITUTIONS ARE TRYING TO

INSTITUTIONS ARE TRYING TO RAPIDLY FIND OUT WHAT WORKS.

RAPIDLY FIND OUT WHAT WORKS. >> THE DRUG WAS USED TO TREATY

>> THE DRUG WAS USED TO TREATY BOWL I BASS ONE INEFFECTIVE.

BOWL I BASS ONE INEFFECTIVE. ITS BEING TESTED AGAINST

ITS BEING TESTED AGAINST CORONAVIRUS SIMMS, TO HOUSTON

CORONAVIRUS SIMMS, TO HOUSTON METHODIST HOSPITAL IS TAKING

METHODIST HOSPITAL IS TAKING PART IN ONE SEVERAL STUDIES .

PART IN ONE SEVERAL STUDIES . >> WE HAVE SEE PATIENTS

>> WE HAVE SEE PATIENTS CRITICALLY ILL AND ON

CRITICALLY ILL AND ON VENTILATORS TO GET OFF THEM.

VENTILATORS TO GET OFF THEM. AND PEOPLE ON ON THEIR WAY TO A

AND PEOPLE ON ON THEIR WAY TO A VENTILATOR TO NOT AND GOING

VENTILATOR TO NOT AND GOING HOME.

HOME. >> Reporter: ANTHONY POUCHY SAYS

>> Reporter: ANTHONY POUCHY SAYS REMEDIES VEER SETS A NEW

REMEDIES VEER SETS A NEW STANDARD OF CARE.

STANDARD OF CARE. >> WE THINK ITS OPENING THE

>> WE THINK ITS OPENING THE DOOR TO THE FACT THAT WE NOW

DOOR TO THE FACT THAT WE NOW HAVE THE CAPABILITY OF TREATING

HAVE THE CAPABILITY OF TREATING AND I CAN GUARANTEE YOU AS MORE

AND I CAN GUARANTEE YOU AS MORE PEOPLE, MORE COMPANIES, MORE

PEOPLE, MORE COMPANIES, MORE INVESTIGATORS GET INVOLVED IT

INVESTIGATORS GET INVOLVED IT WIG GETTER.

WIG GETTER. >> Reporter: ITS TRICKLE TO GO

>> Reporter: ITS TRICKLE TO GO HOUSTONIANS.

HOUSTONIANS. >> THEY ARE TRYING THINGS SO I

>> THEY ARE TRYING THINGS SO I AM OP SIS MICK TIG.

AM OP SIS MICK TIG. >> Reporter: ONE STUDY SUGGESTS

>> Reporter: ONE STUDY SUGGESTS ITS NOT EFFECTIVE.

ITS NOT EFFECTIVE. >> THE WORLD HEALTH ORGANIZATION

>> THE WORLD HEALTH ORGANIZATION STUDY IN CHINA WAS STOPPED EARLY

STUDY IN CHINA WAS STOPPED EARLY AND IT WAS, IN MY OPINION UNDER

AND IT WAS, IN MY OPINION UNDER POWER TO BE ABLE TO MAKE

POWER TO BE ABLE TO MAKE CONCLUSIONS.

CONCLUSIONS. >> Reporter: THEY GOT INVOLVED

>> Reporter: THEY GOT INVOLVED WITH THE STUDY ON MARCH 6

WITH THE STUDY ON MARCH 6 TINGth AND ENROLLED 50 PATIENT

TINGth AND ENROLLED 50 PATIENT FROM HOUSTON METRO HOSPITAL.

FROM HOUSTON METRO HOSPITAL. OUT OF THE 50, 30 RECOVERED AND

OUT OF THE 50, 30 RECOVERED AND WE WANT HOME.

WE WANT HOME. LIVE FROM THE TEXAS MEDICAL

The Description of Remdesivir showing promise in COVID-19 fight